tirzepatide pdufa date FDA Grants a New Indication for Obesity Management Drugs to Watch 2026: 11

Neoadjuvant Treatment with Selpercatinib in RET-Altered Thyroid Cancers

The Cardiovascular continuum extended: aging effects on the aorta and microvasculature

Every patient is different, but obesity commonly contributes to conditions such as: High blood pressure Prediabetes Type 2 diabetes Sleep apnea High cholesterol Knee and hip arthritis Fatty liver disease Cardiovascular disease For many patients, treating obesity is about improving overall healthnot simply losing weight

GLP-1s prompt the body to produce more insulin, which reduces blood sugar

Health plans to acquire Erlanger, invest $2B: Questions and answers | Chief Healthcare ExecutivePrisma Health plans to acquire Erlanger, invest $2B: Questions and answers | Chief Healthcare Executive William H

Her transparency and willingness to address public scrutiny provide a positive example, highlighting the importance of self-acceptance and resilience in the face of media pressures